Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Universal Resources | v328258_ex32-2.htm |
EXCEL - IDEA: XBRL DOCUMENT - Universal Resources | Financial_Report.xls |
10-K - FORM 10-K - Universal Resources | v328258_10k.htm |
EX-31.1 - EXHIBIT 31.1 - Universal Resources | v328258_ex31-1.htm |
EX-31.2 - EXHIBIT 31.2 - Universal Resources | v328258_ex31-2.htm |
Exhibit 32.1
Chief Executive Officer Certification (Section 906)
CERTIFICATION PURSUANT TO
18 U.S.C., SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), I, the undersigned Chief Executive Officer of Global Immune Technologies, Inc., (the “Company”), herby certify that, to the best of my knowledge, the Annual Report on Form 10-K of the Company for the period ended March 31, 2012 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. A signed original of this written statement required by Section 906 has been provided to the registrant and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request.
Dated: October 31, 2012
Global Immune Technologies, Inc. | |
/s/ Serge Talon | |
President & CEO |